BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37395234)

  • 1. The association between duration of and indications for proton pump inhibitor use and risk of gastric polyps.
    Kroupa R; Pavlik T; Konecny S; Packova B; Dastych M; Pavlovsky Z; Dolina J
    Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):829-835. PubMed ID: 37395234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative risk factors associated with the development of fundic gland polyps.
    Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration.
    Takeda T; Asaoka D; Tajima Y; Matsumoto K; Takeda N; Hiromoto T; Okubo S; Saito H; Aoyama T; Shibuya T; Sakamoto N; Hojo M; Osada T; Nagahara A; Yao T; Watanabe S
    Clin J Gastroenterol; 2017 Oct; 10(5):478-484. PubMed ID: 28660530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
    Gao W; Huang Y; Lu S; Li C
    Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan.
    Hongo M; Fujimoto K;
    J Gastroenterol; 2010 Jun; 45(6):618-24. PubMed ID: 20177714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients.
    Genta RM; Schuler CM; Robiou CI; Lash RH
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):849-54. PubMed ID: 19465154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control analysis of fundic gland polyps and proton-pump inhibitors. A pathologist's perspective.
    Velazquez-Dohorn M; López-Durand CF; Candanedo-González F; Araujo-Villalvazo EA; Gamboa-Domínguez A
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(1):42-47. PubMed ID: 31126726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies.
    Zelter A; Fernández JL; Bilder C; Rodríguez P; Wonaga A; Dorado F; Galich M; Viola LA
    Dig Dis Sci; 2011 Jun; 56(6):1743-8. PubMed ID: 21127978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China.
    Cao H; Qu R; Zhang Z; Kong X; Wang S; Jiang K; Wang B
    Chin Med J (Engl); 2014; 127(7):1239-43. PubMed ID: 24709173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
    Brito HLF; Barros C; Freire MV; Silva Filho MND; Nascimento TV
    Arq Gastroenterol; 2018; 55(4):380-384. PubMed ID: 30785522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report.
    Nakashima M; Naoe H; Komohara Y; Waki K; Miyamoto H; Sakai Y; Kojima T; Kanemitsu T; Yao K; Tanaka Y
    In Vivo; 2024; 38(3):1465-1469. PubMed ID: 38688629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton-pump inhibitor-induced fundic gland polyps with hematemesis.
    Tanaka M; Kataoka H; Yagi T
    Clin J Gastroenterol; 2019 Apr; 12(2):193-195. PubMed ID: 30251013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological analysis of fundic gland polyps secondary to PPI therapy.
    Fukuda M; Ishigaki H; Sugimoto M; Mukaisho KI; Matsubara A; Ishida H; Moritani S; Itoh Y; Sugihara H; Andoh A; Ogasawara K; Murakami K; Kushima R
    Histopathology; 2019 Oct; 75(4):537-545. PubMed ID: 31087669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric Xanthomas and Fundic Gland Polyps as Endoscopic Risk Indicators of Gastric Cancer.
    Yamashita K; Suzuki R; Kubo T; Onodera K; Iida T; Saito M; Arimura Y; Endo T; Nojima M; Nakase H
    Gut Liver; 2019 Mar; 13(4):409-414. PubMed ID: 30600671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing histological pattern of gastric polyps in an ethnically heterogeneous population.
    Peretz A; Fuchs T; Livovsky DM; Turvall E; Pappo O; Ackerman Z
    Scand J Gastroenterol; 2012 Sep; 47(8-9):907-13. PubMed ID: 22577830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of Gastric Juice Microenvironment in Patients with Fundic Gland Polyp and Hyperplastic Polyp.
    Gao H; Chang L; Wang L; Zhou X; Wang N
    Pathobiology; 2021; 88(6):383-391. PubMed ID: 34500447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
    Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
    Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps.
    Ljubicić N; Banić M; Kujundzić M; Antić Z; Vrkljan M; Kovacević I; Hrabar D; Doko M; Zovak M; Mihatov S
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):727-30. PubMed ID: 10445791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.